ToplineA class of diabetes and weight loss drugs that includes Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro could also help protect against a variety of cancers, according to new research published Friday, adding to mounting evidence the injections offer numerous additional health benefits as pressure builds for insurers and public health providers to cover the […]
